Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | intracellular kinase | 0.0052 | 0.0125 | 0.0125 |
Brugia malayi | Raf kinase | 0.0202 | 0.0723 | 0.0723 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0055 | 0.0137 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0052 | 0.0125 | 0.5 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0229 | 0.083 | 0.083 |
Onchocerca volvulus | 0.0133 | 0.0449 | 1 | |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0055 | 0.0137 | 0.0137 |
Loa Loa (eye worm) | TKL/RAF/RAF protein kinase | 0.0119 | 0.039 | 0.0391 |
Schistosoma mansoni | protein kinase | 0.2523 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0055 | 0.0137 | 0.0373 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.0507 | 0.0508 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0031 | 0.004 | 0.004 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0055 | 0.0137 | 0.0137 |
Brugia malayi | P38 map kinase family protein 2 | 0.0128 | 0.0426 | 0.0426 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0449 | 0.045 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0052 | 0.0125 | 0.0125 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0055 | 0.0137 | 0.0039 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0031 | 0.004 | 0.004 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0117 | 0.0384 | 0.0384 |
Schistosoma mansoni | atypical protein kinase C | 0.0031 | 0.004 | 0.004 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0765 | 0.2975 | 1 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0052 | 0.0125 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0229 | 0.083 | 0.0832 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0117 | 0.0384 | 0.0384 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0055 | 0.0137 | 0.0137 |
Echinococcus multilocularis | protein kinase shaggy | 0.0052 | 0.0125 | 0.0125 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0055 | 0.0137 | 1 |
Echinococcus granulosus | protein kinase c iota type | 0.0031 | 0.004 | 0.004 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0052 | 0.0125 | 0.0126 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0128 | 0.0426 | 0.0426 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0128 | 0.0426 | 0.0426 |
Brugia malayi | Stress-activated protein kinase jnk-1 | 0.0229 | 0.083 | 0.083 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0229 | 0.083 | 0.083 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0031 | 0.004 | 0.004 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0128 | 0.0426 | 0.1055 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0055 | 0.0137 | 0.0137 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0031 | 0.004 | 0.004 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0128 | 0.0426 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0055 | 0.0137 | 0.0137 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0052 | 0.0125 | 0.0125 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0052 | 0.0125 | 0.0125 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0055 | 0.0137 | 0.0039 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0031 | 0.004 | 0.004 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0128 | 0.0426 | 0.1055 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0055 | 0.0137 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.2516 | 0.9974 | 1 |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0052 | 0.0125 | 0.5 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0128 | 0.0426 | 1 |
Brugia malayi | protein kinase C II. | 0.0031 | 0.004 | 0.004 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0128 | 0.0426 | 0.0426 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0055 | 0.0137 | 0.0373 |
Echinococcus granulosus | protein kinase shaggy | 0.0052 | 0.0125 | 0.0125 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0055 | 0.0137 | 1 |
Echinococcus multilocularis | protein kinase c iota type | 0.0031 | 0.004 | 0.004 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0449 | 0.045 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0128 | 0.0426 | 0.0426 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.2523 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.2523 | 1 | 1 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0055 | 0.0137 | 0.0373 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.2523 | 1 | 1 |
Loa Loa (eye worm) | STE/STE11/ASK protein kinase | 0.0765 | 0.2975 | 0.2983 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0055 | 0.0137 | 0.0039 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0052 | 0.0125 | 0.0126 |
Echinococcus multilocularis | raf serine:threonine protein kinase | 0.0217 | 0.0782 | 0.0782 |
Loa Loa (eye worm) | hypothetical protein | 0.0759 | 0.2949 | 0.2957 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0055 | 0.0137 | 1 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0128 | 0.0426 | 0.0426 |
Echinococcus granulosus | raf serine:threonine protein kinase | 0.0217 | 0.0782 | 0.0782 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.0765 | 0.2975 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.0449 | 0.045 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0217 | 0.0782 | 0.0782 |
Brugia malayi | MAP kinase sur-1 | 0.0055 | 0.0137 | 0.0137 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0055 | 0.0137 | 0.0039 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0031 | 0.004 | 0.004 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0128 | 0.0426 | 0.0426 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0055 | 0.0137 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0052 | 0.0125 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0055 | 0.0137 | 0.0137 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0117 | 0.0384 | 0.0385 |
Loa Loa (eye worm) | hypothetical protein | 0.015 | 0.0515 | 0.0516 |
Entamoeba histolytica | protein kinase, putative | 0.0052 | 0.0125 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0055 | 0.0137 | 0.0373 |
Echinococcus granulosus | Protein kinase C brain isozyme | 0.0031 | 0.004 | 0.004 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0128 | 0.0426 | 0.0427 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0229 | 0.083 | 0.083 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0031 | 0.004 | 0.004 |
Loa Loa (eye worm) | raf kinase | 0.0216 | 0.0777 | 0.0779 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.